Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles M Beasley

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
European Urology|March 26, 2004
A multicenter, randomized, double-blind, crossover study to evaluate patient preference between tadalafil and sildenafilAlexander von Keitz, Jacob Rajfer, Scott Segal, et al.
The Journal of Clinical Psychiatry|February 8, 2007
Early symptomatic worsening during treatment with fluoxetine in major depressive disorder: prevalence and implicationsCristina Cusin, Maurizio Fava, Jay D Amsterdam, et al.
British Journal of Clinical Pharmacology|July 19, 2012
Effects of atomoxetine on the QT interval in healthy CYP2D6 poor metabolizersCorina Loghin, Harry Haber, Charles M Beasley, et al.
Journal of Clinical Psychopharmacology|November 19, 2003
A double-blind, randomized, placebo-controlled trial of olanzapine in the prevention of psychotic relapseCharles M Beasley, Virginia K Sutton, Susan H Hamilton, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 3, 2002
Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementiaKarena M Meehan, Huei Wang, Stacy R David, et al.
Journal of Andrology|May 4, 2005
Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trialJay M Young, Robert A Feldman, Stephen M Auerbach, et al.
Psychotherapy and Psychosomatics|December 16, 2006
Treatment-associated suicidal ideation and adverse effects in an open, multicenter trial of fluoxetine for major depressive episodesRoy H Perlis, Charles M Beasley, James D Wines, et al.
Journal of the American College of Cardiology|August 16, 2005
The combined use of ibutilide as an active control with intensive electrocardiographic sampling and signal averaging as a sensitive method to assess the effects of tadalafil on the human QT intervalCharles M Beasley, Malcolm I Mitchell, Alex A Dmitrienko, et al.
The Journal of Clinical Psychiatry|August 3, 2010
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief reportRoger E Meyer, Carl Salzman, Eric A Youngstrom, et al.
The Journal of Clinical Psychiatry|August 28, 2010
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statementRoger E Meyer, Carl Salzman, Eric A Youngstrom, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
European Urology|March 26, 2004
A multicenter, randomized, double-blind, crossover study to evaluate patient preference between tadalafil and sildenafilAlexander von Keitz, Jacob Rajfer, Scott Segal, et al.
The Journal of Clinical Psychiatry|February 8, 2007
Early symptomatic worsening during treatment with fluoxetine in major depressive disorder: prevalence and implicationsCristina Cusin, Maurizio Fava, Jay D Amsterdam, et al.
British Journal of Clinical Pharmacology|July 19, 2012
Effects of atomoxetine on the QT interval in healthy CYP2D6 poor metabolizersCorina Loghin, Harry Haber, Charles M Beasley, et al.
Journal of Clinical Psychopharmacology|November 19, 2003
A double-blind, randomized, placebo-controlled trial of olanzapine in the prevention of psychotic relapseCharles M Beasley, Virginia K Sutton, Susan H Hamilton, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 3, 2002
Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementiaKarena M Meehan, Huei Wang, Stacy R David, et al.
Journal of Andrology|May 4, 2005
Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trialJay M Young, Robert A Feldman, Stephen M Auerbach, et al.
Psychotherapy and Psychosomatics|December 16, 2006
Treatment-associated suicidal ideation and adverse effects in an open, multicenter trial of fluoxetine for major depressive episodesRoy H Perlis, Charles M Beasley, James D Wines, et al.
Journal of the American College of Cardiology|August 16, 2005
The combined use of ibutilide as an active control with intensive electrocardiographic sampling and signal averaging as a sensitive method to assess the effects of tadalafil on the human QT intervalCharles M Beasley, Malcolm I Mitchell, Alex A Dmitrienko, et al.
The Journal of Clinical Psychiatry|August 3, 2010
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief reportRoger E Meyer, Carl Salzman, Eric A Youngstrom, et al.
The Journal of Clinical Psychiatry|August 28, 2010
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statementRoger E Meyer, Carl Salzman, Eric A Youngstrom, et al.
Pageof 3